Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.
Our Bureau, New Delhi Friday, January 30, 2026, 08:00 Hrs [IST] ...
T cells sit at the center of modern immunotherapy, yet many of the rules that govern their activation, differentiation, dysfunction (e.g., exhaustion), and ...
New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results